<SEC-DOCUMENT>0000950170-25-043263.txt : 20250321
<SEC-HEADER>0000950170-25-043263.hdr.sgml : 20250321
<ACCEPTANCE-DATETIME>20250321163616
ACCESSION NUMBER:		0000950170-25-043263
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250321
FILED AS OF DATE:		20250321
DATE AS OF CHANGE:		20250321

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			I-Mab
		CENTRAL INDEX KEY:			0001778016
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39173
		FILM NUMBER:		25761055

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 400, 2440 RESEARCH BLVD
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		(301) 670 2800

	MAIL ADDRESS:	
		STREET 1:		SUITE 400, 2440 RESEARCH BLVD
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>nasdaq_notice_-_3-21-25.htm
<DESCRIPTION>6-K
<TEXT>
<html>
 <head>
  <title>6-K</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="border-top:2.25pt double;padding-top:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, D.C. 20549</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM 6-K</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REPORT OF FOREIGN PRIVATE ISSUER</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PURSUANT TO RULE 13a-16 OR 15d-16 UNDER</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">THE SECURITIES EXCHANGE ACT OF 1934</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the month of March 2025</font></p>
  <p style="margin-left:33.333%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:33.333%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commission File Number: 001-39173</font></p>
  <p style="margin-left:33.333%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:33.333%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I-MAB</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2440 Research Boulevard, Suite 400</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rockville, MD 20850</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Address of principal executive offices)</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Form 20-F &#9746;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;Form 40-F &#9744;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="border-top:2.25pt double;padding-top:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:13.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:13.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Incorporation by Reference</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Report on Form 6-K (the &#x201c;Report&#x201d;) shall be deemed to be incorporated by reference into the registration statements on Form S-8 (File No. 333-279842, File No. 333-265684, File No. 333-256603 and File No. 333-239871) of I-Mab (including any prospectuses forming a part of such registration statements) and to be a part thereof from the date on which this Report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT INDEX</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:10%;box-sizing:content-box;"></td>
    <td style="width:90%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Exhibit No.</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Description</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="imab-ex99_1.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">99.1</font></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="imab-ex99_1.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Press Release - March 21, 2025</font></a></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:50%;box-sizing:content-box;"></td>
    <td style="width:5%;box-sizing:content-box;"></td>
    <td style="width:2%;box-sizing:content-box;"></td>
    <td style="width:43%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="3" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">I-MAB</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="3" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">:</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Joseph Skelton</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">:</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Joseph Skelton</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">:</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date: March 21, 2025</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>imab-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.4in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit 99.1</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img44095488_0.jpg" alt="img44095488_0.jpg" style="width:202px;height:85px;"></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">I-Mab Announces Receipt Of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">ROCKVILLE, MD, March 21, 2025 (GLOBE NEWSWIRE)- I-Mab (NASDAQ: IMAB) (&#x201c;I-Mab&#x201d; or the &#x201c;Company&#x201d;), announced today that on March 19, 2025 it received a written notice (the &#x201c;Notice&#x201d;) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement under the Nasdaq Listing Rules (the &#x201c;Listing Rules&#x201d;). Based on the closing bid price of the Company&#x2019;s listed securities for the period from February 3, 2025 to March 18, 2025, the Company has not met the minimum bid price requirement set forth in Listing Rule 5450(a)(1) during that period. The Notice is only a notification of deficiency and has no immediate effect on the listing of the Company&#x2019;s American Depositary Shares (&#x201c;ADS&#x201d;). The Company&#x2019;s ADSs will continue to trade on the Nasdaq Global Market at this time. The Company&#x2019;s receipt of the Notice does not impact the Company&#x2019;s business, operations or reporting requirements with the U.S. Securities and Exchange Commission.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The Notice states that under Listing Rule 5810(c)(3)(A) the Company is provided with a period of 180 calendar days, or until September 15, 2025, to regain compliance with the Listing Rules. To regain compliance with the Listing Rules, the closing bid price of the Company&#x2019;s ADSs must meet or exceed $1.00 per ADS for at least ten consecutive business days, unless Nasdaq exercises its discretion to extend this ten-day period. In the event the Company does not regain compliance by September 15, 2025, the Company may be eligible for an additional 180 calendar day period to regain compliance or may face delisting.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The Company intends to continue to monitor the closing bid price of its ADSs between now and September 15, 2025. The Company is currently evaluating options to regain compliance and intends to timely regain compliance with Nasdaq&#x2019;s continued listing requirement. Although the Company will use all reasonable efforts to achieve compliance with the Minimum Bid Requirement, there can be no assurance that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other Nasdaq continued listing requirements. If it appears that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that the Company&#x2019;s securities will be subject to delisting.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The Company fully intends to resolve the deficiency and regain compliance with the Listing Rules.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">About I-Mab</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer. I-Mab has established operations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.4in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">in Rockville, Maryland, and Short Hills, New Jersey. For more information, please visit </font><font><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">https://www.i-mabbiopharma.com</font></font><font style="color:#262626;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> and follow us on </font><font><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">LinkedIn</font></font><font style="color:#262626;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> and </font><font><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">X</font></font><font style="color:#262626;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">I-Mab Forward Looking Statements</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This release contains forward-looking statements. These statements are made under the &#x201c;safe harbor&#x201d; provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as &#x201c;will&#x201d;, &#x201c;expects&#x201d;, &#x201c;believes&#x201d;, &#x201c;designed to&#x201d;, &#x201c;anticipates&#x201d;, &#x201c;future&#x201d;, &#x201c;intends&#x201d;, &#x201c;plans&#x201d;, &#x201c;potential&#x201d;, &#x201c;estimates&#x201d;, &#x201c;confident&#x201d;, and similar terms or the negative thereof. I-Mab may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about I-Mab&#x2019;s beliefs and expectations, are forward-looking statements. Forward-looking statements in this press release include, without limitation, statements regarding the Company&#x2019;s intention to resolve the deficiency and regain compliance with the Nasdaq Listing Rules. Forward-looking statements involve inherent risks and uncertainties that may cause actual results to differ materially from those contained in these forward-looking statements, including but not limited to the following: I-Mab&#x2019;s ability to demonstrate the safety and efficacy of its drug candidates; the clinical results for its drug candidates, which may or may not support further development or New Drug Application/Biologics License Application (NDA/BLA) approval; the content and timing of decisions made by the relevant regulatory authorities regarding regulatory approval of I-Mab&#x2019;s drug candidates; I-Mab&#x2019;s ability to achieve commercial success for its drug candidates, if approved; I-Mab&#x2019;s ability to obtain and maintain protection of intellectual property for its technology and drugs; I-Mab&#x2019;s reliance on third parties to conduct drug development, manufacturing and other services; and I-Mab&#x2019;s limited operating history and I-Mab&#x2019;s ability to obtain additional funding for operations and to complete the development and commercialization of its drug candidates, as well as those risks more fully discussed in the &#x201c;Risk Factors&#x201d; section in I-Mab&#x2019;s most recent annual report on Form 20-F, as well as discussions of potential risks, uncertainties, and other important factors in I-Mab&#x2019;s subsequent filings with the SEC. All forward-looking statements are based on information currently available to I-Mab. I-Mab undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required by law.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">I-Mab Investor &amp; Media Contacts</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">PJ Kelleher</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">LifeSci Advisors</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">+1-617-430-7579</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">pkelleher@lifesciadvisors.com</font></font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">IR@imabbio.com</font></font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img44095488_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img44095488_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "E 88# 2(  A$! Q$!_\0
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M-/4^7J3KX#$T<9A*LZ&)PU6%>A7IRE"=*K2DI0G&<;--25M-UOU/["/V;O\
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MV^.WQ_UCX.S0K-<_$+X)?'/1-&_=K)*GB*#X:Z]K'ATVP96VW,NM:78VT3J
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MKGPE\+O -U;K(FX!XQ_PE'B?Q!;R;,I)]F0NVZ-57R;]CW_D[/\ 9C_[+_\
M!_\ ]3_P_7])5L73Q>79M*EK&A',,(Y7OS5,-2G3K>G)652FUKK!O1NR_F7#
MX.K@LSR:-72>(GEF,4;;4L55A5H^O/1=.I?^_I=:O_3+HHKR7X\_%WP]\ _@
MQ\3_ (S^*7C71/AKX*U_Q;=0R2B$ZA/I5A+-IVCPR'(6[UO4_L>CV6<!KR^@
M4D!LC^(:-*IB*M*A1@ZE:M4A2I4XJ\IU*DE"$(KJY2DHI=V?W76K4\/1JUZT
MXTZ-"G.M5J2=HPITXN<YR?2,8Q<F^B1_&A_P7V_:0_X6]^V+'\)-'OOM'A7]
MGGPY!X6DCB<M!)XZ\21VNO\ BV8,DC0RM96SZ#HC_();6\TS4+=V#;XT_#"N
ML\>>-?$'Q(\;^,/B'XLO&U'Q1XZ\3Z]XO\0WS\&[UKQ'JEUJ^ISA>B+)>7<S
M)&N%C0JB@*H _3O]I/\ 87/PE_X)J_L:?M.0:/+;^)OB)XA\9W_Q'N/LY\PZ
M'\1/(U/X2S7-P3D6,7AKPLMS9Q[$"W7BJX'[S<'K^S<NC@.%,MX<R*I.,9UY
M4\LH.*257&_5<1C*]5K1J-:M2JZV;]K7I1?Q7/XDS.>/XMS3B7/J<)2A0C4S
M2O&5W*E@OK>&P6'HIJZ<J%"M2NKI>RP]62?NV/U._P"#;[]HW?:_&S]E?6[\
M?N9K7XQ> K:>6-?]>MEX:\=V-J)&\V9V\GPKJ<5K -L21ZM=E#YDSK_5'7^;
ME_P3\_:'E_9<_:]^"?Q?ENVM- TOQ9;:%XT;S5BBD\$^*@WA_P 2FX=P5$-G
MI]^^IDD?+)8QL,%17^D/;7$%Y;P7=K+'/;74,5Q;SQ,'BF@G19898W'#1R1L
MKHPX96!'!K\"\7,E_L[B59C3ARX?.:$<1=*T5B\.HT,5%=+N/L*\GUE6DWK<
M_H;P>SO^TN&'EU6?-B,DQ$L-9N\G@\0Y5\+)^49.O0BND:$5M8\\^,O_ "1_
MXK?]DV\<_P#J+ZI7^7A7^I+\2-%O_$GP\\>^'=*2.75->\%^*-%TV.658(I+
M_5-#OK&S229\)#&]Q/&KRN0L:DNW -?P\_\ #A/_ (*%"'S9/#/PJAEPI^RR
M_%;0!<9(!*Y6-K;*Y(;_ $C!(.TL,$^UX1YYDV38?/5FN:8'+G7KY>Z*QF)I
M8=U5"&+4W!5)1YE!SBI-:1YE>USPO&3(LYSC$9!+*LLQN81P]',57>$P]2NJ
M3J3P;IJ;A%\KFH2Y4]9<KML?%GP$_P""?/[7_P"T[X)F^(OP,^#6I^/?!L&L
MWGA^76[/Q#X.TN)-7T^*WFO+/[-KOB'2[TM!%=6[-(ML83YJA9&.0/8KW_@C
MU_P4@L;6XO)OV8?%$L5M$\SQV7B;P!J%TZQJ69;>RLO%EQ=W4I PD-O#+-(V
M%C1F(!_K3_X) _LO?%S]D/\ 9=U/X5?&S3=$T;QC<?$WQ-XE@L]%\1Z5XDM9
M-(U*RT:WLY_MVE3SP+)+)97&;=V$R*JET4M@?J1JFJ:;HFFW^LZQ?VFEZ3I5
MG<ZCJ>I7]Q%:6-A86<+W%W>7EU,R0V]M;01O-/-*ZQQ1HSNP4$UMG'B_FN%S
M?'83*L/DF88"CBI4L)B8+%5WB**<>22JT,:J4W+5*5."BV](Z6,,D\&\FQN3
M8#&YIBL[P.85\)"MC,,YX2C'#5FKS@Z5; RJPC&VL:E1R2;O+8_RU/%/A7Q+
MX(\1:SX1\9:!K'A;Q3X=U"XTK7O#OB#3KK2=:T?4K5S'<V.I:;?107=G=0N,
M/#/$CC(.,$$_T5_\$ ?VW/&_AWXQ?\,<^--?O=:^'/C_ $G7-8^&-GJ5U+=-
MX.\9Z!8S:WJ.E:*9=[VVB>(]#M-4N[G3DD6TM=4TR&[M+>*74-1DF_/;_@L%
M\<_A'^T+^W)\0/'GP7U&TUWPE:^'_"/A2Z\46%HUK8^*?$/AK36LM6UBR>2.
M*6_LT)M])M=3>,+?P:6EQ;-+9O;32>E?\$+OA'XI^(G_  4#^''C'1[.X;P]
M\&M&\8^./%NJ""5K*SMM2\*:UX,TBQFN54Q0WFIZIXDB-G#(P>XALKYXU9+:
M9D_2.)/89SP#C<7G.#6#J5,D>8?5ZZ:J8+,(X;VV'A%SC&I"JL2X4DFHSDIN
ME./OSB_S3AE5\D\0\#@\EQCQM.GGL<N^L8=_N\=ETL2J.)E.,)2A.D\,IUI-
M2G3C*FJL)>Y"2_O.HHHK^0S^R!DDD<,;RRND442-)))(RI''&BEG=W8A41%!
M9F8A54$D@"O\G#]H7XG77Q]_:0^.WQMO)9+B3XK?%[XA>/8#*SGR-/\ $_BK
M5-5TNRB$F&CMK#3;JTL;2$A1!:VT,(550 ?ZBG[5WBN;P)^RW^TIXXMI6@N/
M!OP!^,?BN"96V-#-X>^'?B/5XI5?^%HWLU<-_"1GM7^5!H5J#LX]/\YZG@9^
MOY#^FOH[8"#?$^922<U_9N"I/JH/ZU7KQ])M89V_N?-?RO\ 26S&=.'"V6QD
MU!K-,=5C?24T\'0P[M?>$7B5??W[)K4['1M.SL^7/3M^!/\ +'_ZZ_6[]DSQ
M>NL?#IO"5U(G]I>"[N2"W4[%DN-!U>:XU"QE+27+W%Y-::B=6LIWCMX[:PT]
M-"MBQ>9 WYAZ'9@[3C.,#M^?;''.?YBOISX->*)_ /BS3M=03R6#JVFZW:09
M+WNC7CQ&[C6,7%HD\]K+%!J=A#//';'4["R:Y+0HZG^L\OF\-6IU4G;:HM[P
ME9222WDOBBKJ\HQN]S^'>*,/',\!7PK:]H[5:$FTN6O3=Z=V]E-.5*4M;0J3
M<5=*WZC44R.2*>*&XMY4N+:YAANK6YBW&&YM;F))[6Z@9E5G@N8)(YX'*CS(
MI$<##"GU]DFI)2BTTTFFM4TU=-/JFM4?A<HRA*4)Q<9PDXRC)6E&46U*+3U3
M3333V9J:)HNK>)-8TKP]H.GW6K:WKFHV>DZ1I=C$T]YJ.I:A<1VME96L* M+
M/<W$L<,2#[SN!QUK^JK]B;]D+0?V7?A_')J4-GJ?Q9\5V=O/XY\11A)A9 [+
MB+PCH=Q@E-$TJ4+]IGC*MKFIQMJ5P!;QZ99Z=\'_ /!*+]ER%HKG]IKQGIPD
M<R:AH/PIM+J(%8Q$9;#Q'XRC5@<R&07/AO1Y 08O+\02O$Q?3[A/W*K^)?I#
M>)]7,LPK<"9+B7'*\MJ16?5J,[?7\RIM267N4=\+ETDO;P;M4QZE&<?]CIRG
M_I']$WP6H9-E.'\3^(\)&>=9Q1E+A;#5X)_V7D]:+A_:JC)>[C<W@Y/#5$KT
M<KE"5.?_  H5H4RBBBOY:/[;"BBB@#'\0>'M!\6:+J?AOQ1HND^(_#VM6<NG
MZQH6NZ?::MI&JV,Z[9K/4--OHI[.\MI5XD@N(9(VXRIP*_F5_P""B7_!&"\T
M"QUWXR?L=:;?ZMI5NEQJGB?X%"2YU'6+"!=TMU?_  RN9GFO=9MHDW3/X,OI
M+C6$V2KX=O=4::RT"V_J"HZ=:^?X@X9RGB3#>PS+#1E5II_5L9!*.*PLGK>E
M5M=P;UG1GS4JGVH.2C*/R7%W!60\:9?+ YQADZL8R6#S"BHPQ^!J/53P]=Q;
M<'*SJ8>HIT*MESTW*,)1_@'_ &2-#N+;3/&^NW2F)[K6+'0!;2Q/'<VTVB6\
MUU>>9OPRB1]9@B:,HK++:.'^9<+]@5]0?M,:GX4^(?QM^*/B?P5HVBZ)I^I^
M+M2ETTZ%86>FV7B!K8QV%UK=Y%91Q17&J^*+JUF\03ZM*&N[R^U*;^T9)O.C
MFLOF @@D$$$$@@C!!'!!!Y!!X(/2O\5?$?B' \2\<\38[+,9''9=ALSK95@<
M1#W85L)E-LOHXJG3YZG)1QT<.\=22DTXXF^DN:,?P/!<./A;!T,G]O'%PPTL
M0H8R%-TX8KFQ%2I*JH2E-P;<U>FYS<(\J4G'E;2BBBOB3I/LC]@7Q@_@_P#:
MG^&K&4QV?B:;5_!]^H.WSTU[2+R+3HB>A UZ'2)L$'<8@HPQ!'].%?R*?!35
MGT'XR?"?6XV*-I/Q*\#:B"#CBS\3Z7<,#V*LL95@>&4E6!!(K^NNO]*_H29M
M4Q'!/%V2SDY0ROB6CCJ2;OR0S;+:-*4(]H>TRN=116G/4J2WDS]=\.Z[EEV.
MP[=U1QD:D?)5Z,8M+LKT6[7W;=M=2BBBO[5/T,*_!7_@XK_Y,3\&?]G*> ?_
M % /BO7[U5^"O_!Q7_R8GX,_[.4\ _\ J ?%>OK.!?\ DL.'O^QE1_\ ;CX_
MQ _Y(SB/_L6U?_2H'\2-?Z77[($S6W['7[-UP@!>#]GOX73(&SM+1> =&=0V
M.<$J <<XK_-%K_2Z_8_A:Y_8[_9MMU(5KC]GOX6PJS9*JTO@+1HP2!R0"P)Q
MSBOU[QKM]0R"^WU[%7]/8TKGXYX&?\C+B"V_U#"6_P#!]4_E<OO^#BW]KZUO
M;RU7X8? TK;7=S I.E>+6.V&9XURP\3KN.%&3M7)YVC.!5_XB-?VO_\ HE_P
M,_\ !3XM_P#FIKN;W_@V]_:+NKR[NO\ A?OP>'VFZN)P/[)\7C FE>0#'V1L
M8W=-S8Z;FZFM_P 0VO[1G_1?O@]_X*O%_P#\A5U*KX-65UDU[*_[G'[Z7_Y=
M^7]79RNCXV7=GG-KZ?OLN_\ EGG_ %9GZX_\$BO^"CGQB_;YF^-:?%7POX$\
M.)\.(_!SZ,?!EKJ]JUTWB%M<6\%^-4U/4@ZQ#3(# 83&09)0X(VU^,G_  <=
M?\G>_"?_ +()I7_J;^,Z_;/_ ()0?\$V/B3_ ,$_)OC*_C[X@>#?'"?$J/PB
MFF+X4L]9M6T]O#K:TURUZVJQ1!UN!JD0A6%25,+EV(=0OXF?\''7_)WOPG_[
M()I7_J;^,Z^>X3>2R\4L0^'O8_V2\OJ_5?JZJ1I?[AAU6Y552FOW_M.;F7Q7
M:T/I.+EG<?"B@N(O;_VQ]?H_6_K,J<JW_(PQ'L>=T6Z?\#V7+ROX;7]ZY\<?
M\$7KO['_ ,%'/V?CDC[3=>,+3@D9^T>"M?7!P1D''0Y![@]*\:_X*5?!,?L_
M_MQ?M%?#JVLEL-%7Q[?>+?#%O&#Y,?A?Q[#!XST*&%\;9%L[#7(["1DX6XM)
MHF"R1NB]Y_P2'N_L?_!1G]E\YQ]H\9ZI:=0,_:/"7B%<<@]?08)Z CK7Z>?\
M'(WP3_L;XM_ ;]H#3K,K:^.O!FK_  U\27,4>V%=;\#ZDVN:#/=/C#WFIZ-X
MIO[2)LDFT\-(A $2EOT/$YC]2\2\#@YRM2SCAAT4KV3Q&$QF-Q5&3UM=4H8F
M$;J[=1):Z/\ -L-EGU[POQV.A&]7)>*?;2DE=K#8S!8'"UDM+V=:>&G)ZI1I
MMNR5U^B__!&+]J+3)?\ @F1K^J^)M11IOV5I_B3HVM27TX!7P[I6GR_$/PXS
M D-%8II>M'0[1N$8Z1-&IW1/C^+;QOXJU;XA^.?%GC753+<:UXV\4ZWXEOAN
M>XEDU'Q#JMSJ4\:L1OE/GW;1Q@#) 4*HX%?6'[.?[6^J? W]FW]L[X%VLMVJ
M_M)>"/ >B:5)&AEMK74=!\7I;>(HIAD?98]8^'_B'Q3;27"_ZZXL].MY0ZE
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M2?1H9;*:.758;JZ5K:VFTY&:[BN+A6@A>%9)5:-6!_G^^-7[5/@OX;>![/\
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M&*"A1P[J5U#/LIH12C&G@L;6O3QN%I1TI8''M.$53HX?'82A!4C^UZBOP/\
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M$8TV-FZ><MWX@6]@3(9C8/( 4B>OZ/:_+O\ X):_"F3PO\)O$WQ0U&V,5_\
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M)B\'?$B^>.STWXAO!;ILMM!^(<GD66OW;I'';>/0EY=W-S>^.88K;^973=8
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M%?$*E#"^1_$3X#?![XKAW\?_  ^\/:_>.@C.KM:OIVO+&%"JB>(-)DL=:6-
M!LB%]Y:D A.*^4-<_P"":7P U.9Y]+U;XB^' S$K::?KVDWME&"<[0-9\/:C
M?,%X"EM0)QG<6)R/T+HK^$.*/!_PNXTQ$\9Q/P%POF^.J-RJYC6RK#4LRJM_
M\_LRPT*&.JKLJF(DD[M)-L_M.M@,%B&Y5L+1J2>\W3BIOUFDI/[SYI^"'[)W
MP?\ @.1?^&-'GUGQ21(K>,?%#VVI:]%%+N#0:<T5K:Z?H\/ELT3MI=C:W-S$
M?+O;FZ4*%^EJ**^JX;X7X=X.RG#Y%PMDN79#E&&NZ6 RS"T\+0YY6]I6J*FE
M*OB*O*G6Q->53$5I+FJU)RU-J-&EAZ:I4:<*5..T8145ZNV[=M9.[?5L****
M]XU"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
